Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol. 2016 05; 141(2):386-401.

View in: PubMed

collapse authors with profiles